Home Shareholders and Investors General information on the Company Investor Agenda

Investor Agenda

Find out more …

General information
on the Company
Economic and financial
information
Corporate governance
Information for investors
Contact

Filter results

Add Events

THU

07/11 2019

January-September 2019 Results

ROVI will release its nine-month period ended 30 September 2019 Financial Results on the 7th of November, before the opening of the Stock Market.

TUE

30/07 2019

First Half 2019 Financial Results

ROVI will release its First Half 2019 Financial Results on the 30th of July, before the opening of the Stock Market. ROVI Management...

TUE

19/03 2019

Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia

ROVI today announced topline results from the pivotal study PRISMA-3. ROVI Management team will hold a telephone conference to...

TUE

26/02 2019

Full Year 2018 Financial Results

ROVI will release its Full Year 2018 Financial Results on the 26th of February, before the opening of the Stock Market. ROVI Management...

THU

26/07 2018

First Half 2018 Financial Results

ROVI will release its First Half 2018 Financial Results on the 26th of July, before the opening of the Stock Market. ROVI Management...

TUE

20/02 2018

Full Year 2017 Financial Results

ROVI will release its Full Year 2017 Financial Results on the 20th of February, before the opening of the Stock Market. ROVI Management team will...

WED

26/07 2017

First Half 2017 Financial Results

ROVI will release its First Half 2017 Financial Results on the 26th of July, before the opening of the Stock Market.

WED

05/07 2017

Pago de Dividendos

WED

31/05 2017

ROVI General shareholders meeting 2017

FRI

21/04 2017

First Quarter 2017 Financial Results

ROVI will release its First Quarter 2017 financial results on Friday, April 21st, before the market opens.

THU

16/02 2017

Full Year 2016 Financial Results

ROVI will release its Full Year 2016 Financial Results on the 16th of February, before the opening of the Stock Market. ROVI Management team will...

TUE

08/11 2016

January-September 2016 Results

ROVI will release its nine-month period ended 30 September 2016 Financial Results on the 8th of November, before the opening of the Stock Market.

Pages

In accordance with the provisions of the General Data Protection Regulation, any personal data that may be provided by the User through this Website will be processed by Laboratorios Farmacéuticos Rovi, S.A. (hereinafter, "Rovi") in order to respond to the User's request, application or query.

The contact information for ROVI is as follows:

Identity: Laboratorios Farmacéuticos ROVI, S.A. (Rovi) – Tax ID No.: A-28041283.
Postal address: Julián Camarillo, 35, 28037 Madrid.
Telephone: 91 375 62 30.
Email Address: protecciondedatos@rovi.es
DPO Contact: dporovi@rovi.es

The data will be processed on the legal basis of consent having been granted by the individual providing said data. The User may withdraw said consent at any time, although this shall not affect the lawfulness of the processing operations that had been carried out prior to said withdrawal. Provision of data is voluntary; however, if data is not provided, the queries made cannot be responded to. The data will be kept for the amount of time necessary to respond to the User's request and, subsequently, as long as any type of legal responsibility may last as a result thereof. In the event that data belonging to third parties is provided, it is the responsibility of the User making the data provision to inform said third parties on all of the provisions herein and, especially, on the provisions of Article 14 of the General Data Protection Regulation. The User must also have obtained prior consent from said third parties to make such a data provision.

The User is responsible for the information provided through this Website being true. Thus, the User is to be held liable for the veracity of all data provided and is responsible for conveniently keeping said data up to date so that it reflects reality. The User will be held liable for any false information or inaccurate statements provided and for any losses and/or damages this causes to ROVI or to third parties.

ROVI guarantees the security and confidentiality of the personal data provided. To this end, all measures of a technical and organisational nature that are appropriate have been implemented so as to avoid the alteration, loss, and/or unauthorised processing of –and access to– the User's data, as stipulated in the General Data Protection Regulation.

Users are hereby informed of the possibility to exercise their rights to access, rectify, delete, limit processing, oppose, and request data portability through a written, signed request that contains the following information: name, surname(s), address for the purposes of notification, photocopy of identity card or passport, and specific mention of the right to be exercised. Such a request must be sent to any of the aforementioned contact addresses for ROVI (normal post or email). Should any possible violation of your rights arise, you may file a complaint with the Spanish Data Protection Agency.

The ROVI Group is active in a number of countries, including both other Group companies, customers and suppliers. Some of these third parties may be located in other countries, so that personal data may be transferred outside the countries where we and our customers are located.

This includes countries outside the European Union, and also countries that do not have laws providing specific protection for personal data. ROVI has taken steps to ensure that all personal data is adequately protected and that all transfers of personal data outside the EU are carried out in accordance with European Union standards of legality and security. If personal data is transferred outside the EU to a country that the European Commission does not determine provides an adequate level of protection for personal data, transfers will be made under an agreement that covers the EU requirements for the transfer of personal data outside the EU, such as the standard contractual clauses approved by the European Commission.

All ROVI Group Companies are located within the European Union, except ROVI Biotech Limited UK. The United Kingdom has an adequacy decision approved by the European Commission and is therefore considered to have an adequate level of protection

TERMS AND CONDITIONS

1.- These Terms and Conditions of Use set the rules to which the use of this Website's Contents are subject (hereinafter, the "Contents"). By accessing, downloading or using the Contents, you are considered a User, and said actions imply acceptance of all the terms and conditions contained in this document, in the Website's Privacy Policy and Legal Notice. The User must read these conditions each time he/she accesses, downloads or uses the Contents, as they may be modified in the future.

2.- Certain sections of the Rovi websites have been designed for specific audiences including the general public, healthcare professionals, shareholders of ROVI, etc.
When the Website is directed to healthcare professionals, a specific mention will be made.
Within the various services included in the Rovi websites, is to provide information on ROVI activities, products, health information and the health field. While some medical information may appear in the ROVI websites, if you are in a medical process, please refer to your doctor or to your healthcare provider. We do not offer personalized medical diagnosis or specific medical advice for patients.

3.- The Contents, as well as trademarks and other distinctive marks that appear therein, are the property of their respective holders or of Laboratorios Farmacéuticos Rovi, S.A. (hereinafter, "Rovi"). Users can access the Contents for consultation or for downloading in accordance with the conditions set out in this document. To this end, a content use license, non – exclusive and royalty free, is recognize to the user for medical and educational purposes. Such content use license is granted with the same terms and conditions for Contents updated and improvements. This license may be revoked unilaterally at any time, by merely notifying the User on this Web page.

It is prohibited to elude, disable or otherwise manipulate (or to attempt to elude, deactivate, or manipulate) the Website's security (or other) features, and to use the Contents for commercial or advertising purposes. Likewise, it is prohibited to use the Contents with the purpose of harming the assets, rights, or interests of Rovi, the authors or third parties.

4.- The User must refrain from: a) transforming or modifying the Contents; b) deleting or altering the author's name in the Contents; c) extracting or reusing all or a substantial part of the Contents in other works – unless express permission is granted by the author.

5.- The User commits to properly using the Contents in accordance with the law, these Terms and Conditions of Use, and any other regulations and/or instructions which may be of application. The User shall be held liable to Rovi, to the author, and to third parties for any losses or damages that may be caused by a failure to comply with these obligations.

6.- These Terms of Use are governed entirely by Spanish law. For the resolution of any disputes relating to their interpretation or application, the User expressly agrees to turn to the jurisdiction of the courts of Madrid (Spain).

Investor Agenda

Pages

Pages

What is a "cookie"?

What types of cookies exist?

Who is responsible for the management of cookies on this Website?

What cookies are used by this Website and what are they used for?

How long are cookies stored for?

What is the legal basis for using cookies?

To whom will the cookies be communicated and who can access them?

What rights exist in relation to the use of cookies by this website?

How can I manage cookies?

A) FORM FOR EXERCISE OF RIGHT OF ACCESS

Particulars of applicant:

He/she requests:

B) FORM FOR EXERCISE OF RIGHT TO RECTIFICATION

Particulars of applicant:

He/she requests:

C) FORM FOR EXERCISE OF THE RIGHT TO ERASURE

Particulars of applicant:

He/she requests:

Reasons for erasure:

D) FORM FOR EXERCISE OF THE RIGHT TO RESTRICTION OF PROCESSING

Particulars of applicant:

He/she requests:

E) FORM FOR EXERCISE OF THE RIGHT TO DATA PORTABILITY

Particulars of applicant:

He/she requests:

F) FORM FOR EXERCISE OF THE RIGHT TO OBJECT

Particulars of applicant:

He/she requests: